These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31982140)

  • 1. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
    Wu YK; Hu LF; Lou DS; Wang BC; Tan J
    Biochem Biophys Res Commun; 2020 Mar; 524(1):142-149. PubMed ID: 31982140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.
    Ye P; Liu J; Xu W; Liu D; Ding X; Le S; Zhang H; Chen S; Chen M; Xia J
    Hepatology; 2019 May; 69(5):1946-1964. PubMed ID: 30582764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver.
    Wang S; Yan ZZ; Yang X; An S; Zhang K; Qi Y; Zheng J; Ji YX; Wang PX; Fang C; Zhu XY; Shen LJ; Yan FJ; Bao R; Tian S; She ZG; Tang YD
    Hepatology; 2018 Apr; 67(4):1320-1338. PubMed ID: 29077210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
    Wu L; Liu Y; Zhao Y; Li M; Guo L
    Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
    Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
    Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
    Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
    Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling.
    Wang J; Ma J; Nie H; Zhang XJ; Zhang P; She ZG; Li H; Ji YX; Cai J
    Hepatology; 2021 Jan; 73(1):104-125. PubMed ID: 32191345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
    Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
    Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
    An S; Zhao LP; Shen LJ; Wang S; Zhang K; Qi Y; Zheng J; Zhang XJ; Zhu XY; Bao R; Yang L; Lu YX; She ZG; Tang YD
    Hepatology; 2017 Dec; 66(6):1866-1884. PubMed ID: 28718215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
    Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
    World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.
    Wang PX; Zhang XJ; Luo P; Jiang X; Zhang P; Guo J; Zhao GN; Zhu X; Zhang Y; Yang S; Li H
    Nat Commun; 2016 Feb; 7():10592. PubMed ID: 26882989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice.
    Gong J; Fang C; Zhang P; Wang PX; Qiu Y; Shen LJ; Zhang L; Zhu XY; Tian S; Li F; Wang Z; Huang Z; Wang A; Zhang XD; She ZG
    Hepatology; 2019 Feb; 69(2):524-544. PubMed ID: 29381809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional involvement of dual specificity phosphatase 16 (DUSP16), a c-Jun N-terminal kinase-specific phosphatase, in the regulation of T helper cell differentiation.
    Musikacharoen T; Bandow K; Kakimoto K; Kusuyama J; Onishi T; Yoshikai Y; Matsuguchi T
    J Biol Chem; 2011 Jul; 286(28):24896-905. PubMed ID: 21613215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.
    Xiang M; Wang PX; Wang AB; Zhang XJ; Zhang Y; Zhang P; Mei FH; Chen MH; Li H
    J Hepatol; 2016 Jun; 64(6):1365-77. PubMed ID: 26860405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma.
    Lee S; Syed N; Taylor J; Smith P; Griffin B; Baens M; Bai M; Bourantas K; Stebbing J; Naresh K; Nelson M; Tuthill M; Bower M; Hatzimichael E; Crook T
    Br J Cancer; 2010 Jul; 103(2):265-74. PubMed ID: 20551953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GCSF deficiency attenuates nonalcoholic fatty liver disease through regulating GCSFR-SOCS3-JAK-STAT3 pathway and immune cells infiltration.
    Zhang Y; Zhou X; Liu P; Chen X; Zhang J; Zhang H; Li S; Chen Y; Song X; Wang J; Zeng H; Zhang X; Tang C; Yu C; Li Y; Xu C
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G531-G542. PubMed ID: 33470903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise ameliorates insulin resistance via regulating TGFβ-activated kinase 1 (TAK1)-mediated insulin signaling in liver of high-fat diet-induced obese rats.
    Zhang Y; Wan J; Xu Z; Hua T; Sun Q
    J Cell Physiol; 2019 May; 234(5):7467-7474. PubMed ID: 30367484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Jun/C7ORF41/NF-κB axis mediates hepatic inflammation and lipid accumulation in NAFLD.
    Yan FJ; Wang X; Wang SE; Hong HT; Lu J; Ye Q; Zheng YL; Wang YJ
    Biochem J; 2020 Feb; 477(3):691-708. PubMed ID: 31957809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice.
    Zhao Y; Wang F; Gao L; Xu L; Tong R; Lin N; Su Y; Yan Y; Gao Y; He J; Kong L; Yuan A; Zhuge Y; Pu J
    Hepatology; 2018 Sep; 68(3):897-917. PubMed ID: 29573006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MKP-5 Relieves Lipotoxicity-Induced Islet β-Cell Dysfunction and Apoptosis via Regulation of Autophagy.
    Zhao T; Ma J; Li L; Teng W; Tian Y; Ma Y; Wang W; Yan W; Jiao P
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.